Development of HCC in patients receiving adefovir dipivoxil for lamivudine-resistant hepatitis B virus mutants
{{output}}
Aim: To identify factors for the development of hepatocellular carcinoma (HCC) in the patients who receive adefovir add-on lamivudine for treatment of lamivudine-resistant hepatitis B virus (HBV) mutants. ... ...
